US Stock MarketDetailed Quotes

Arcus Biosciences (RCUS)

Watchlist
  • 22.340
  • -0.940-4.04%
Close Apr 10 16:00 ET
  • 22.340
  • 0.0000.00%
Post 16:20 ET
2.80BMarket Cap-6.79P/E (TTM)

Arcus Biosciences (RCUS) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
0.31%981M
0.31%981M
-23.69%831M
-5.99%911M
0.20%997M
28.85%978M
28.85%978M
36.30%1.09B
4.19%969M
4.30%995M
-Cash and cash equivalents
48.00%222M
48.00%222M
18.41%238M
58.97%248M
3.78%192M
18.11%150M
18.11%150M
9.24%201M
-32.17%156M
-22.27%185M
-Short-term investments
-8.33%759M
-8.33%759M
-33.22%593M
-18.45%663M
-0.62%805M
31.01%828M
31.01%828M
44.39%888M
16.14%813M
13.13%810M
Receivables
-36.00%16M
-36.00%16M
-33.33%14M
-39.39%20M
-47.50%21M
-40.48%25M
-40.48%25M
-62.50%21M
-10.81%33M
11.11%40M
-Accounts receivable
-45.00%11M
-45.00%11M
-31.25%11M
-46.43%15M
-57.14%15M
-47.37%20M
-47.37%20M
-69.23%16M
-17.65%28M
6.06%35M
-Accrued interest receivable
0.00%5M
0.00%5M
-40.00%3M
0.00%5M
20.00%6M
25.00%5M
25.00%5M
25.00%5M
66.67%5M
66.67%5M
Other current assets
-23.08%10M
-23.08%10M
-29.41%12M
-25.00%15M
-55.17%13M
-56.67%13M
-56.67%13M
-37.04%17M
5.26%20M
16.00%29M
Total current assets
-0.89%1.01B
-0.89%1.01B
-23.96%857M
-7.44%946M
-3.10%1.03B
22.26%1.02B
22.26%1.02B
27.78%1.13B
3.65%1.02B
4.83%1.06B
Non current assets
Net PPE
-14.89%40M
-14.89%40M
-12.50%42M
-10.20%44M
-9.80%46M
-7.84%47M
-7.84%47M
-4.00%48M
8.89%49M
37.84%51M
-Gross PPE
2.27%90M
2.27%90M
----
----
----
7.32%88M
7.32%88M
----
----
----
-Accumulated depreciation
-21.95%-50M
-21.95%-50M
----
----
----
-32.26%-41M
-32.26%-41M
----
----
----
Investments and advances
107.14%29M
107.14%29M
400.00%10M
-60.00%16M
-92.00%8M
-86.92%14M
-86.92%14M
-98.68%2M
-50.00%40M
11.11%100M
Other non current assets
-13.70%63M
-13.70%63M
-13.33%65M
-8.00%69M
-8.97%71M
-31.13%73M
-31.13%73M
-30.56%75M
-31.19%75M
-30.36%78M
Total non current assets
-1.49%132M
-1.49%132M
-6.40%117M
-21.34%129M
-45.41%125M
-49.24%134M
-49.24%134M
-59.55%125M
-29.91%164M
-4.18%229M
Total assets
-0.96%1.14B
-0.96%1.14B
-22.20%974M
-9.36%1.08B
-10.60%1.16B
5.02%1.15B
5.02%1.15B
5.12%1.25B
-2.79%1.19B
3.11%1.29B
Liabilities
Current liabilities
Payables
126.32%43M
126.32%43M
223.08%42M
93.33%29M
37.50%22M
11.76%19M
11.76%19M
-35.00%13M
7.14%15M
-44.83%16M
-accounts payable
133.33%42M
133.33%42M
223.08%42M
93.33%29M
37.50%22M
5.88%18M
5.88%18M
-23.53%13M
25.00%15M
-42.86%16M
-Total tax payable
0.00%1M
0.00%1M
----
----
----
--1M
--1M
----
----
----
Current accrued expenses
27.08%122M
27.08%122M
33.33%112M
41.38%82M
32.69%69M
54.84%96M
54.84%96M
33.33%84M
5.45%58M
6.12%52M
Current debt and capital lease obligation
8.33%13M
8.33%13M
18.18%13M
9.09%12M
9.09%12M
9.09%12M
9.09%12M
22.22%11M
--11M
--11M
-Current capital lease obligation
8.33%13M
8.33%13M
18.18%13M
9.09%12M
9.09%12M
9.09%12M
9.09%12M
22.22%11M
--11M
--11M
Current deferred liabilities
-58.82%35M
-58.82%35M
-50.48%52M
-37.17%71M
-41.94%72M
-6.59%85M
-6.59%85M
1.94%105M
9.71%113M
27.84%124M
Other current liabilities
28.57%18M
28.57%18M
700.00%16M
700.00%16M
1,600.00%17M
366.67%14M
366.67%14M
-60.00%2M
-75.00%2M
-75.00%1M
Current liabilities
2.21%231M
2.21%231M
9.30%235M
5.53%210M
-5.88%192M
22.83%226M
22.83%226M
7.50%215M
10.56%199M
13.97%204M
Non current liabilities
Long term debt and capital lease obligation
106.25%99M
106.25%99M
108.51%98M
--97M
--48M
--48M
--48M
--47M
----
----
-Long term debt
106.25%99M
106.25%99M
108.51%98M
--97M
--48M
--48M
--48M
--47M
----
----
Non current deferred liabilities
-81.62%43M
-81.62%43M
-81.66%53M
-71.96%60M
-9.50%219M
-23.78%234M
-23.78%234M
-11.35%289M
-35.15%214M
-26.67%242M
Other non current liabilities
-14.01%135M
-14.01%135M
11.76%152M
15.22%159M
18.57%166M
10.56%157M
10.56%157M
-6.21%136M
-4.17%138M
-3.45%140M
Total non current liabilities
-36.90%277M
-36.90%277M
-35.81%303M
-10.23%316M
13.35%433M
-2.23%439M
-2.23%439M
0.21%472M
-25.74%352M
-19.58%382M
Total liabilities
-23.61%508M
-23.61%508M
-21.69%538M
-4.54%526M
6.66%625M
5.06%665M
5.06%665M
2.38%687M
-15.75%551M
-10.40%586M
Shareholders'equity
Share capital
30.86%2.12B
30.86%2.12B
13.30%1.82B
13.34%1.79B
13.71%1.78B
23.34%1.62B
23.34%1.62B
24.09%1.6B
24.86%1.58B
27.32%1.56B
-common stock
30.86%2.12B
30.86%2.12B
13.30%1.82B
13.34%1.79B
13.71%1.78B
23.34%1.62B
23.34%1.62B
24.09%1.6B
24.86%1.58B
27.32%1.56B
Retained earnings
-31.18%-1.49B
-31.18%-1.49B
-32.85%-1.38B
-31.50%-1.24B
-45.84%-1.24B
-33.33%-1.13B
-33.33%-1.13B
-35.16%-1.04B
-35.72%-946M
-37.14%-853M
Gains losses not affecting retained earnings
----
----
----
----
----
----
----
133.33%1M
75.00%-1M
75.00%-1M
Total stockholders'equity
30.10%631M
30.10%631M
-22.83%436M
-13.54%549M
-24.89%531M
4.98%485M
4.98%485M
8.65%565M
12.19%635M
17.83%707M
Total equity
30.10%631M
30.10%631M
-22.83%436M
-13.54%549M
-24.89%531M
4.98%485M
4.98%485M
8.65%565M
12.19%635M
17.83%707M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 0.31%981M0.31%981M-23.69%831M-5.99%911M0.20%997M28.85%978M28.85%978M36.30%1.09B4.19%969M4.30%995M
-Cash and cash equivalents 48.00%222M48.00%222M18.41%238M58.97%248M3.78%192M18.11%150M18.11%150M9.24%201M-32.17%156M-22.27%185M
-Short-term investments -8.33%759M-8.33%759M-33.22%593M-18.45%663M-0.62%805M31.01%828M31.01%828M44.39%888M16.14%813M13.13%810M
Receivables -36.00%16M-36.00%16M-33.33%14M-39.39%20M-47.50%21M-40.48%25M-40.48%25M-62.50%21M-10.81%33M11.11%40M
-Accounts receivable -45.00%11M-45.00%11M-31.25%11M-46.43%15M-57.14%15M-47.37%20M-47.37%20M-69.23%16M-17.65%28M6.06%35M
-Accrued interest receivable 0.00%5M0.00%5M-40.00%3M0.00%5M20.00%6M25.00%5M25.00%5M25.00%5M66.67%5M66.67%5M
Other current assets -23.08%10M-23.08%10M-29.41%12M-25.00%15M-55.17%13M-56.67%13M-56.67%13M-37.04%17M5.26%20M16.00%29M
Total current assets -0.89%1.01B-0.89%1.01B-23.96%857M-7.44%946M-3.10%1.03B22.26%1.02B22.26%1.02B27.78%1.13B3.65%1.02B4.83%1.06B
Non current assets
Net PPE -14.89%40M-14.89%40M-12.50%42M-10.20%44M-9.80%46M-7.84%47M-7.84%47M-4.00%48M8.89%49M37.84%51M
-Gross PPE 2.27%90M2.27%90M------------7.32%88M7.32%88M------------
-Accumulated depreciation -21.95%-50M-21.95%-50M-------------32.26%-41M-32.26%-41M------------
Investments and advances 107.14%29M107.14%29M400.00%10M-60.00%16M-92.00%8M-86.92%14M-86.92%14M-98.68%2M-50.00%40M11.11%100M
Other non current assets -13.70%63M-13.70%63M-13.33%65M-8.00%69M-8.97%71M-31.13%73M-31.13%73M-30.56%75M-31.19%75M-30.36%78M
Total non current assets -1.49%132M-1.49%132M-6.40%117M-21.34%129M-45.41%125M-49.24%134M-49.24%134M-59.55%125M-29.91%164M-4.18%229M
Total assets -0.96%1.14B-0.96%1.14B-22.20%974M-9.36%1.08B-10.60%1.16B5.02%1.15B5.02%1.15B5.12%1.25B-2.79%1.19B3.11%1.29B
Liabilities
Current liabilities
Payables 126.32%43M126.32%43M223.08%42M93.33%29M37.50%22M11.76%19M11.76%19M-35.00%13M7.14%15M-44.83%16M
-accounts payable 133.33%42M133.33%42M223.08%42M93.33%29M37.50%22M5.88%18M5.88%18M-23.53%13M25.00%15M-42.86%16M
-Total tax payable 0.00%1M0.00%1M--------------1M--1M------------
Current accrued expenses 27.08%122M27.08%122M33.33%112M41.38%82M32.69%69M54.84%96M54.84%96M33.33%84M5.45%58M6.12%52M
Current debt and capital lease obligation 8.33%13M8.33%13M18.18%13M9.09%12M9.09%12M9.09%12M9.09%12M22.22%11M--11M--11M
-Current capital lease obligation 8.33%13M8.33%13M18.18%13M9.09%12M9.09%12M9.09%12M9.09%12M22.22%11M--11M--11M
Current deferred liabilities -58.82%35M-58.82%35M-50.48%52M-37.17%71M-41.94%72M-6.59%85M-6.59%85M1.94%105M9.71%113M27.84%124M
Other current liabilities 28.57%18M28.57%18M700.00%16M700.00%16M1,600.00%17M366.67%14M366.67%14M-60.00%2M-75.00%2M-75.00%1M
Current liabilities 2.21%231M2.21%231M9.30%235M5.53%210M-5.88%192M22.83%226M22.83%226M7.50%215M10.56%199M13.97%204M
Non current liabilities
Long term debt and capital lease obligation 106.25%99M106.25%99M108.51%98M--97M--48M--48M--48M--47M--------
-Long term debt 106.25%99M106.25%99M108.51%98M--97M--48M--48M--48M--47M--------
Non current deferred liabilities -81.62%43M-81.62%43M-81.66%53M-71.96%60M-9.50%219M-23.78%234M-23.78%234M-11.35%289M-35.15%214M-26.67%242M
Other non current liabilities -14.01%135M-14.01%135M11.76%152M15.22%159M18.57%166M10.56%157M10.56%157M-6.21%136M-4.17%138M-3.45%140M
Total non current liabilities -36.90%277M-36.90%277M-35.81%303M-10.23%316M13.35%433M-2.23%439M-2.23%439M0.21%472M-25.74%352M-19.58%382M
Total liabilities -23.61%508M-23.61%508M-21.69%538M-4.54%526M6.66%625M5.06%665M5.06%665M2.38%687M-15.75%551M-10.40%586M
Shareholders'equity
Share capital 30.86%2.12B30.86%2.12B13.30%1.82B13.34%1.79B13.71%1.78B23.34%1.62B23.34%1.62B24.09%1.6B24.86%1.58B27.32%1.56B
-common stock 30.86%2.12B30.86%2.12B13.30%1.82B13.34%1.79B13.71%1.78B23.34%1.62B23.34%1.62B24.09%1.6B24.86%1.58B27.32%1.56B
Retained earnings -31.18%-1.49B-31.18%-1.49B-32.85%-1.38B-31.50%-1.24B-45.84%-1.24B-33.33%-1.13B-33.33%-1.13B-35.16%-1.04B-35.72%-946M-37.14%-853M
Gains losses not affecting retained earnings ----------------------------133.33%1M75.00%-1M75.00%-1M
Total stockholders'equity 30.10%631M30.10%631M-22.83%436M-13.54%549M-24.89%531M4.98%485M4.98%485M8.65%565M12.19%635M17.83%707M
Total equity 30.10%631M30.10%631M-22.83%436M-13.54%549M-24.89%531M4.98%485M4.98%485M8.65%565M12.19%635M17.83%707M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More